David Law1, Mark Pimentel. 1. GI Motility Program, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.
Abstract
BACKGROUND: Evidence suggests a role for small intestinal bacterial overgrowth (SIBO) in IBS. Recently, the question has arisen whether the lactulose breath test (LBT) is abnormal in IBS subjects due to overlapping GERD and proton-pump inhibitor (PPI) usage. AIM: The aim of this study was to compare the prevalence of an abnormal LBT in IBS patients either receiving or not receiving PPI therapy. METHODS: Consecutive Rome I positive IBS patients referred for LBT completed a questionnaire regarding their symptoms and medication use. All subjects then underwent an LBT. The prevalence of abnormal breath test results and hydrogen production were compared based on PPI usage. RESULTS: Of a total of 555 (429 female) subjects, 106 (19.1%) subjects reported current PPI use. Among those on PPI, 46.2% had a positive LBT. This was not different from the 56.3% positive LBT in non-PPI subjects (OR = 0.67, CI = 0.436-1.017, P = 0.06). No differences in hydrogen parameter were seen with PPI. The average amplitude of rise (first peak) in PPI users was 28.0 +/- 35.3 ppm from baseline; in non-PPI users it was 27.5 +/- 29.1 ppm (P = 0.89). The average rise in the second peak in PPI users was 48.5 +/- 43.8 ppm from baseline; in non-PPI users, it was 49.3 +/- 37.6 ppm (P = 0.87). The time to first peak in PPI users was 56.4 +/- 23.0 min; in non-PPI users, it was 58.2 +/- 26.1 min (P = 0.58). However, among subjects receiving PPI only 7.5% had methane detection on LBT, which is significantly different from the 15.4% of subjects not taking PPI. CONCLUSION: PPI therapy does not effect hydrogen production on lactulose breath tests in IBS patients. However, there may be an effect on methane.
BACKGROUND: Evidence suggests a role for small intestinal bacterial overgrowth (SIBO) in IBS. Recently, the question has arisen whether the lactulose breath test (LBT) is abnormal in IBS subjects due to overlapping GERD and proton-pump inhibitor (PPI) usage. AIM: The aim of this study was to compare the prevalence of an abnormal LBT in IBSpatients either receiving or not receiving PPI therapy. METHODS: Consecutive Rome I positive IBSpatients referred for LBT completed a questionnaire regarding their symptoms and medication use. All subjects then underwent an LBT. The prevalence of abnormal breath test results and hydrogen production were compared based on PPI usage. RESULTS: Of a total of 555 (429 female) subjects, 106 (19.1%) subjects reported current PPI use. Among those on PPI, 46.2% had a positive LBT. This was not different from the 56.3% positive LBT in non-PPI subjects (OR = 0.67, CI = 0.436-1.017, P = 0.06). No differences in hydrogen parameter were seen with PPI. The average amplitude of rise (first peak) in PPI users was 28.0 +/- 35.3 ppm from baseline; in non-PPI users it was 27.5 +/- 29.1 ppm (P = 0.89). The average rise in the second peak in PPI users was 48.5 +/- 43.8 ppm from baseline; in non-PPI users, it was 49.3 +/- 37.6 ppm (P = 0.87). The time to first peak in PPI users was 56.4 +/- 23.0 min; in non-PPI users, it was 58.2 +/- 26.1 min (P = 0.58). However, among subjects receiving PPI only 7.5% had methane detection on LBT, which is significantly different from the 15.4% of subjects not taking PPI. CONCLUSION: PPI therapy does not effect hydrogen production on lactulose breath tests in IBSpatients. However, there may be an effect on methane.
Authors: Mark Pimentel; Henry C Lin; Pedram Enayati; Brian van den Burg; Hyo-Rang Lee; Jin H Chen; Sandy Park; Yuthana Kong; Jeffrey Conklin Journal: Am J Physiol Gastrointest Liver Physiol Date: 2005-11-17 Impact factor: 4.052
Authors: M Fried; H Siegrist; R Frei; F Froehlich; P Duroux; J Thorens; A Blum; J Bille; J J Gonvers; K Gyr Journal: Gut Date: 1994-01 Impact factor: 23.059
Authors: Andrea Riedl; Marco Schmidtmann; Andreas Stengel; Miriam Goebel; Anna-Sophia Wisser; Burghard F Klapp; Hubert Mönnikes Journal: J Psychosom Res Date: 2008-04-28 Impact factor: 3.006
Authors: Kang Nyeong Lee; Oh Young Lee; Dong Hee Koh; Won Sohn; Sang Pyo Lee; Dae Won Jun; Hang Lak Lee; Byung Chul Yoon; Ho Soon Choi; Joon Soo Hahm Journal: J Korean Med Sci Date: 2013-06-03 Impact factor: 2.153
Authors: Magnus Simrén; Giovanni Barbara; Harry J Flint; Brennan M R Spiegel; Robin C Spiller; Stephen Vanner; Elena F Verdu; Peter J Whorwell; Erwin G Zoetendal Journal: Gut Date: 2012-06-22 Impact factor: 23.059
Authors: Ali Rezaie; Michelle Buresi; Anthony Lembo; Henry Lin; Richard McCallum; Satish Rao; Max Schmulson; Miguel Valdovinos; Salam Zakko; Mark Pimentel Journal: Am J Gastroenterol Date: 2017-03-21 Impact factor: 10.864